Therapeutic combination comprising a NMDA receptors blocker and a narcotic analgesic substance

Details for Australian Patent Application No. 2006278933 (hide)

Owner Chiesi Farmaceutici S.P.A.

Inventors Villetti, Gino; Chiesi, Paolo

Agent Lord and Company

Pub. Number AU-A-2006278933

PCT Pub. Number WO2007/017058

Priority 05016391.4 28.07.05 EP

Filing date 18 July 2006

Wipo publication date 15 February 2007

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/485 (2006.01) - Morphinan derivatives, e.g. morphine, codeine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/017058 Priority application(s): WO2007/017058

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278944-Adenine derivatives

2006278928-Syringe device with a dose limiting mechanism and an additional safety mechanism